Tech Company Financing Transactions
BenchSci Funding Round
iNovia Capital and TCV joined a $63 million Series C funding round for BenchSci. The round was announced by the company on 2/2/2022.
Transaction Overview
Company Name
Announced On
2/2/2022
Transaction Type
Venture Equity
Amount
$63,000,000
Round
Series C
Investors
iNovia Capital (Lead Investor) (Dennis Kavelman)
TCV (Lead Investor) (Matthew Brennan)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
559 College St. 201
Toronto ON, M6G 1A9
Canada
Toronto ON, M6G 1A9
Canada
Phone
Undisclosed
Website
Email Address
Overview
As a team of former bench scientists, we experienced challenges finding commercial antibodies. So we spent two years building machine learning software to extract antibody usage data in the form of published figures, decoding millions of papers and making the data easily discoverable for scientists. The result: BenchSci.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 2/2/2022: Vajro venture capital transaction
Next: 2/2/2022: FTX US venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs